Literature DB >> 3083461

Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys.

J L Katz.   

Abstract

Rhesus monkeys undergoing opioid withdrawal either due to withholding morphine administration for 14 h or due to administration of naloxone, were treated with or due to administration of naloxone, were treated with either morphine or clonidine. Morphine eliminated all of the withdrawal signs that developed when morphine was withheld for 14 h. Clonidine also eliminated some but not all signs that developed when morphine was withheld. The frequencies of individual signs prior to drug administration were directly related to the minimal doses necessary to eliminate signs for morphine but not for clonidine. Morphine also eliminated most of the signs precipitated by naloxone, whereas clonidine did not eliminate as many of the naloxone-precipitated signs. Additionally, some of the naloxone-precipitated signs that were eliminated by clonidine were not eliminated by morphine. The present results are consistent with clinical findings indicating an efficacy of clonidine in the treatment of opioid withdrawal through a non-opioid mechanism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083461     DOI: 10.1007/bf00180844

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

Review 1.  Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety.

Authors:  D E Redmond; Y H Huang
Journal:  Life Sci       Date:  1979-12-24       Impact factor: 5.037

2.  Effects of clonidine on morphine withdrawal signs in the rat.

Authors:  L F Tseng; H H Loh; E T Wei
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432

3.  Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey Macaca arctoides.

Authors:  D E Redmond; Y H Huang; D R Snyder; J W Maas
Journal:  Brain Res       Date:  1976-11-12       Impact factor: 3.252

4.  Annual report: evaluation of new compounds for opioid activity (1980).

Authors:  J H Woods; F Medzihradsky; C B Smith; A M Young; H H Swain
Journal:  NIDA Res Monogr       Date:  1981-02

5.  Clonidine in opiate withdrawal.

Authors:  M S Gold; D E Redmond; H D Kleber
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

6.  Clonidine for opiate detoxification: outpatient clinical trials.

Authors:  A M Washton; R B Resnick
Journal:  Am J Psychiatry       Date:  1980-09       Impact factor: 18.112

7.  Cardiovascular changes during morphine withdrawal in the rat: effects of clonidine.

Authors:  J J Buccafusco
Journal:  Pharmacol Biochem Behav       Date:  1983-02       Impact factor: 3.533

8.  Influence of clonidine on the acute dependence response elicited in naive rats by naloxone.

Authors:  R M Eisenberg
Journal:  Life Sci       Date:  1983-04-04       Impact factor: 5.037

9.  Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment.

Authors:  M S Gold; A C Pottash; D R Sweeney; H D Kleber
Journal:  JAMA       Date:  1980-01-25       Impact factor: 56.272

10.  The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms.

Authors:  D S Charney; D E Sternberg; H D Kleber; G R Heninger; D E Redmond
Journal:  Arch Gen Psychiatry       Date:  1981-11
View more
  12 in total

1.  Interactions of clonidine and naloxone on schedule-controlled behavior in opioid-naive mice.

Authors:  J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice.

Authors:  K M Kantak; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.

Authors:  L R Gerak; C Zanettini; W Koek; C P France
Journal:  Psychopharmacology (Berl)       Date:  2015-07-23       Impact factor: 4.530

4.  Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys.

Authors:  S Stevens Negus; Kenner C Rice
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

5.  The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration.

Authors:  Thomas N Greenwell; Brendan M Walker; Pietro Cottone; Eric P Zorrilla; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2008-07-23       Impact factor: 3.533

6.  Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.

Authors:  L R Gerak; C P France
Journal:  J Pharmacol Exp Ther       Date:  2016-03-02       Impact factor: 4.030

7.  Differential mechanisms in the acquisition and expression of heroin-induced place preference.

Authors:  T H Hand; L Stinus; M Le Moal
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Some effects of dopamine transporter and receptor ligands on discriminative stimulus, physiologic, and directly observable indices of opioid withdrawal in rhesus monkeys.

Authors:  Lance R McMahon; Jun-Xu Li; F Ivy Carroll; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2008-07-18       Impact factor: 4.530

9.  Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys.

Authors:  G L Becker; L R Gerak; W Koek; C P France
Journal:  Psychopharmacology (Berl)       Date:  2008-08-23       Impact factor: 4.530

10.  Self administration of heroin and cocaine in morphine-dependent and morphine-withdrawn rhesus monkeys.

Authors:  Lisa R Gerak; Ruggero Galici; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2009-02-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.